Report Detail

Other Global Pharmacokinetics Services Market Size, Status and Forecast 2021-2027

  • RnM2120831
  • |
  • 19 January, 2021
  • |
  • Global
  • |
  • 98 Pages
  • |
  • QYResearch
  • |
  • Other

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Pharmacokinetics Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Small Molecules Pharmacokinetics Services
    • 1.2.3 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
  • 1.3 Market by Application
    • 1.3.1 Global Pharmacokinetics Services Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Small & Medium Enterprise
    • 1.3.3 Large Enterprise
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Pharmacokinetics Services Market Perspective (2016-2027)
  • 2.2 Pharmacokinetics Services Growth Trends by Regions
    • 2.2.1 Pharmacokinetics Services Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Pharmacokinetics Services Historic Market Share by Regions (2016-2021)
    • 2.2.3 Pharmacokinetics Services Forecasted Market Size by Regions (2022-2027)
  • 2.3 Pharmacokinetics Services Industry Dynamic
    • 2.3.1 Pharmacokinetics Services Market Trends
    • 2.3.2 Pharmacokinetics Services Market Drivers
    • 2.3.3 Pharmacokinetics Services Market Challenges
    • 2.3.4 Pharmacokinetics Services Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Pharmacokinetics Services Players by Revenue
    • 3.1.1 Global Top Pharmacokinetics Services Players by Revenue (2016-2021)
    • 3.1.2 Global Pharmacokinetics Services Revenue Market Share by Players (2016-2021)
  • 3.2 Global Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Pharmacokinetics Services Revenue
  • 3.4 Global Pharmacokinetics Services Market Concentration Ratio
    • 3.4.1 Global Pharmacokinetics Services Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Services Revenue in 2020
  • 3.5 Pharmacokinetics Services Key Players Head office and Area Served
  • 3.6 Key Players Pharmacokinetics Services Product Solution and Service
  • 3.7 Date of Enter into Pharmacokinetics Services Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacokinetics Services Breakdown Data by Type

  • 4.1 Global Pharmacokinetics Services Historic Market Size by Type (2016-2021)
  • 4.2 Global Pharmacokinetics Services Forecasted Market Size by Type (2022-2027)

5 Pharmacokinetics Services Breakdown Data by Application

  • 5.1 Global Pharmacokinetics Services Historic Market Size by Application (2016-2021)
  • 5.2 Global Pharmacokinetics Services Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Pharmacokinetics Services Market Size (2016-2027)
  • 6.2 North America Pharmacokinetics Services Market Size by Type
    • 6.2.1 North America Pharmacokinetics Services Market Size by Type (2016-2021)
    • 6.2.2 North America Pharmacokinetics Services Market Size by Type (2022-2027)
    • 6.2.3 North America Pharmacokinetics Services Market Size by Type (2016-2027)
  • 6.3 North America Pharmacokinetics Services Market Size by Application
    • 6.3.1 North America Pharmacokinetics Services Market Size by Application (2016-2021)
    • 6.3.2 North America Pharmacokinetics Services Market Size by Application (2022-2027)
    • 6.3.3 North America Pharmacokinetics Services Market Size by Application (2016-2027)
  • 6.4 North America Pharmacokinetics Services Market Size by Country
    • 6.4.1 North America Pharmacokinetics Services Market Size by Country (2016-2021)
    • 6.4.2 North America Pharmacokinetics Services Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Pharmacokinetics Services Market Size (2016-2027)
  • 7.2 Europe Pharmacokinetics Services Market Size by Type
    • 7.2.1 Europe Pharmacokinetics Services Market Size by Type (2016-2021)
    • 7.2.2 Europe Pharmacokinetics Services Market Size by Type (2022-2027)
    • 7.2.3 Europe Pharmacokinetics Services Market Size by Type (2016-2027)
  • 7.3 Europe Pharmacokinetics Services Market Size by Application
    • 7.3.1 Europe Pharmacokinetics Services Market Size by Application (2016-2021)
    • 7.3.2 Europe Pharmacokinetics Services Market Size by Application (2022-2027)
    • 7.3.3 Europe Pharmacokinetics Services Market Size by Application (2016-2027)
  • 7.4 Europe Pharmacokinetics Services Market Size by Country
    • 7.4.1 Europe Pharmacokinetics Services Market Size by Country (2016-2021)
    • 7.4.2 Europe Pharmacokinetics Services Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Pharmacokinetics Services Market Size (2016-2027)
  • 8.2 Asia-Pacific Pharmacokinetics Services Market Size by Type
    • 8.2.1 Asia-Pacific Pharmacokinetics Services Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Pharmacokinetics Services Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Pharmacokinetics Services Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Pharmacokinetics Services Market Size by Application
    • 8.3.1 Asia-Pacific Pharmacokinetics Services Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Pharmacokinetics Services Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Pharmacokinetics Services Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Pharmacokinetics Services Market Size by Region
    • 8.4.1 Asia-Pacific Pharmacokinetics Services Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Pharmacokinetics Services Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Pharmacokinetics Services Market Size (2016-2027)
  • 9.2 Latin America Pharmacokinetics Services Market Size by Type
    • 9.2.1 Latin America Pharmacokinetics Services Market Size by Type (2016-2021)
    • 9.2.2 Latin America Pharmacokinetics Services Market Size by Type (2022-2027)
    • 9.2.3 Latin America Pharmacokinetics Services Market Size by Type (2016-2027)
  • 9.3 Latin America Pharmacokinetics Services Market Size by Application
    • 9.3.1 Latin America Pharmacokinetics Services Market Size by Application (2016-2021)
    • 9.3.2 Latin America Pharmacokinetics Services Market Size by Application (2022-2027)
    • 9.3.3 Latin America Pharmacokinetics Services Market Size by Application (2016-2027)
  • 9.4 Latin America Pharmacokinetics Services Market Size by Country
    • 9.4.1 Latin America Pharmacokinetics Services Market Size by Country (2016-2021)
    • 9.4.2 Latin America Pharmacokinetics Services Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Pharmacokinetics Services Market Size (2016-2027)
  • 10.2 Middle East & Africa Pharmacokinetics Services Market Size by Type
    • 10.2.1 Middle East & Africa Pharmacokinetics Services Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Pharmacokinetics Services Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Pharmacokinetics Services Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Pharmacokinetics Services Market Size by Application
    • 10.3.1 Middle East & Africa Pharmacokinetics Services Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Pharmacokinetics Services Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Pharmacokinetics Services Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Pharmacokinetics Services Market Size by Country
    • 10.4.1 Middle East & Africa Pharmacokinetics Services Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Pharmacokinetics Services Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Evotec AG (Germany)
    • 11.1.1 Evotec AG (Germany) Company Details
    • 11.1.2 Evotec AG (Germany) Business Overview
    • 11.1.3 Evotec AG (Germany) Pharmacokinetics Services Introduction
    • 11.1.4 Evotec AG (Germany) Revenue in Pharmacokinetics Services Business (2016-2021)
    • 11.1.5 Evotec AG (Germany) Recent Development
  • 11.2 Pacific BioLabs (US)
    • 11.2.1 Pacific BioLabs (US) Company Details
    • 11.2.2 Pacific BioLabs (US) Business Overview
    • 11.2.3 Pacific BioLabs (US) Pharmacokinetics Services Introduction
    • 11.2.4 Pacific BioLabs (US) Revenue in Pharmacokinetics Services Business (2016-2021)
    • 11.2.5 Pacific BioLabs (US) Recent Development
  • 11.3 GVK Biosciences Private Limited (India)
    • 11.3.1 GVK Biosciences Private Limited (India) Company Details
    • 11.3.2 GVK Biosciences Private Limited (India) Business Overview
    • 11.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Introduction
    • 11.3.4 GVK Biosciences Private Limited (India) Revenue in Pharmacokinetics Services Business (2016-2021)
    • 11.3.5 GVK Biosciences Private Limited (India) Recent Development
  • 11.4 Shanghai Medicilon Inc. (China)
    • 11.4.1 Shanghai Medicilon Inc. (China) Company Details
    • 11.4.2 Shanghai Medicilon Inc. (China) Business Overview
    • 11.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Introduction
    • 11.4.4 Shanghai Medicilon Inc. (China) Revenue in Pharmacokinetics Services Business (2016-2021)
    • 11.4.5 Shanghai Medicilon Inc. (China) Recent Development
  • 11.5 Pharmaceutical Product Development, LLC (US)
    • 11.5.1 Pharmaceutical Product Development, LLC (US) Company Details
    • 11.5.2 Pharmaceutical Product Development, LLC (US) Business Overview
    • 11.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Introduction
    • 11.5.4 Pharmaceutical Product Development, LLC (US) Revenue in Pharmacokinetics Services Business (2016-2021)
    • 11.5.5 Pharmaceutical Product Development, LLC (US) Recent Development
  • 11.6 Charles River Laboratories International, Inc. (US)
    • 11.6.1 Charles River Laboratories International, Inc. (US) Company Details
    • 11.6.2 Charles River Laboratories International, Inc. (US) Business Overview
    • 11.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Introduction
    • 11.6.4 Charles River Laboratories International, Inc. (US) Revenue in Pharmacokinetics Services Business (2016-2021)
    • 11.6.5 Charles River Laboratories International, Inc. (US) Recent Development
  • 11.7 PAREXEL International Corporation (US)
    • 11.7.1 PAREXEL International Corporation (US) Company Details
    • 11.7.2 PAREXEL International Corporation (US) Business Overview
    • 11.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Introduction
    • 11.7.4 PAREXEL International Corporation (US) Revenue in Pharmacokinetics Services Business (2016-2021)
    • 11.7.5 PAREXEL International Corporation (US) Recent Development
  • 11.8 Eurofins Scientific, Inc. (Luxembourg)
    • 11.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Details
    • 11.8.2 Eurofins Scientific, Inc. (Luxembourg) Business Overview
    • 11.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Introduction
    • 11.8.4 Eurofins Scientific, Inc. (Luxembourg) Revenue in Pharmacokinetics Services Business (2016-2021)
    • 11.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Development
  • 11.9 Frontage Labs (US)
    • 11.9.1 Frontage Labs (US) Company Details
    • 11.9.2 Frontage Labs (US) Business Overview
    • 11.9.3 Frontage Labs (US) Pharmacokinetics Services Introduction
    • 11.9.4 Frontage Labs (US) Revenue in Pharmacokinetics Services Business (2016-2021)
    • 11.9.5 Frontage Labs (US) Recent Development
  • 11.10 SGS SA (Switzerland)
    • 11.10.1 SGS SA (Switzerland) Company Details
    • 11.10.2 SGS SA (Switzerland) Business Overview
    • 11.10.3 SGS SA (Switzerland) Pharmacokinetics Services Introduction
    • 11.10.4 SGS SA (Switzerland) Revenue in Pharmacokinetics Services Business (2016-2021)
    • 11.10.5 SGS SA (Switzerland) Recent Development
  • 11.11 LGC Limited (UK)
    • 11.11.1 LGC Limited (UK) Company Details
    • 11.11.2 LGC Limited (UK) Business Overview
    • 11.11.3 LGC Limited (UK) Pharmacokinetics Services Introduction
    • 11.11.4 LGC Limited (UK) Revenue in Pharmacokinetics Services Business (2016-2021)
    • 11.11.5 LGC Limited (UK) Recent Development
  • 11.12 Creative Bioarray (US)
    • 11.12.1 Creative Bioarray (US) Company Details
    • 11.12.2 Creative Bioarray (US) Business Overview
    • 11.12.3 Creative Bioarray (US) Pharmacokinetics Services Introduction
    • 11.12.4 Creative Bioarray (US) Revenue in Pharmacokinetics Services Business (2016-2021)
    • 11.12.5 Creative Bioarray (US) Recent Development
  • 11.13 Certara, L.P. (Germany)
    • 11.13.1 Certara, L.P. (Germany) Company Details
    • 11.13.2 Certara, L.P. (Germany) Business Overview
    • 11.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Introduction
    • 11.13.4 Certara, L.P. (Germany) Revenue in Pharmacokinetics Services Business (2016-2021)
    • 11.13.5 Certara, L.P. (Germany) Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Pharmacokinetics Services market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacokinetics Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Small Molecules Pharmacokinetics Services
    Large Molecules (Biopharmaceuticals) Pharmacokinetics Services

    Segment by Application
    Small & Medium Enterprise
    Large Enterprise

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Evotec AG (Germany)
    Pacific BioLabs (US)
    GVK Biosciences Private Limited (India)
    Shanghai Medicilon Inc. (China)
    Pharmaceutical Product Development, LLC (US)
    Charles River Laboratories International, Inc. (US)
    PAREXEL International Corporation (US)
    Eurofins Scientific, Inc. (Luxembourg)
    Frontage Labs (US)
    Shanghai Medicilon Inc. (China)
    Pharmaceutical Product Development, LLC (US)
    Creative Bioarray (US)


    Summary:
    Get latest Market Research Reports on Pharmacokinetics Services . Industry analysis & Market Report on Pharmacokinetics Services is a syndicated market report, published as Global Pharmacokinetics Services Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Pharmacokinetics Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,844.29
    4,266.43
    5,688.58
    3,276.83
    4,915.24
    6,553.65
    427,810.50
    641,715.75
    855,621.00
    291,607.68
    437,411.52
    583,215.36
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report